Therapeutic Biologic GMP Inspections To Become “More Systems-Based”
Executive Summary
Therapeutic biologics manufacturing compliance inspections will move toward the systems-based approach used by the Center for Drug Evaluation & Research, Office of Regulatory Affairs Regional Operations Director Deborah Ralston said